Latest posts tagged with #Lenalidomide on Bluesky
In patients with R/R follicular #lymphoma, treatment with the triplet combo of #tafasitamab, #lenalidomide, and #rituximab led to significantly improved PFS compared with the SOC combo of lenalidomide plus rituximab, at a median 22.4 months vs. 13.9: https://ow.ly/PSaT50YBgcw
#HemeSky
🩸Facts about Myelofibrosis:
Specific Strategies for Anemia
#Myelofibrosis #Hematology #Oncology #BloodDisorders #Anemia #ESAtherapy #Danazol #Thalidomide #Lenalidomide #Hepcidin #Erythropoiesis #MedEd #RareDiseases #HEMEHUB
Among patients with follicular #lymphoma, adding #epcoritamab to the SOC combo of #lenalidomide plus #rituximab outperformed lenalidomide plus rituximab alone, resulting in ORRs of 95% vs. 79%, as well as a lower risk of disease progression or death: https://ow.ly/652R50YrQeT
#HemeSky #MedSky
⚡ Top buzzwords for Department of Veterans Affairs in January 2026: 1: lenalidomide. 2: implantation hypoglossal. 3: inspire implantation. #lenalidomide
meterintelligence.com/reports/agency/departmen...
⚡ Top buzzwords for Department of Veterans Affairs in January 2026: 1: lenalidomide. 2: implantation hypoglossal. 3: inspire implantation. #lenalidomide
meterintelligence.com/reports/agency/departmen...
🩸Facts about Multiple Myeloma:
Treatment Sequencing and Combinations
#MultipleMyeloma #Hematology #MedEd #HEMEHUB #Daratumumab #BispecificAntibodies #Teclistamab #IMiDs #Lenalidomide #Pomalidomide #Carfilzomib #Immunotherapy #Oncology
🩸🔬Today's question!
See the answer and explanation on the next slide.
#MultipleMyeloma #MAIATrial #FrontlineTherapy #Hematology #HemeOnc #ClinicalTrials #CancerTherapy #HEMEHUB #CyBorD #Daratumumab #Lenalidomide #Dexamethasone #DRd #Bortezomib #Thalidomide #Pomalidomide
Among older and frail patients with #MultipleMyeloma #MMsm, a dexamethasone-sparing regimen with #daratumumab and #lenalidomide reduced the risk of progression or death compared with lenalidomide and #dexamethasone alone, at a PFS of 53.4 vs. 22.5 months: https://ow.ly/YXzG50XT7Aw
#HemeSky #OncSky
A phase 3 trial led by MSK’s Dr. Lorenzo Falchi found that adding #epcoritamab to #rituximab + #lenalidomide significantly improves outcomes for people with follicular lymphoma. Epcoritamab received FDA approval based on these findings. #ASH25
Learn more: www.mskcc.org/news/new-tri...
AbbVie Secures FDA Approval for Epcoritamab in Combination Therapy for Relapsed Follicular Lymphoma #United_States #Epcoritamab #North_Chicago #Rituximab #Lenalidomide
The first trial of #Rituximab plus #Lenalidomide in newly diagnosed #FollicularLymphoma in China identified PU.1 as a key regulator of PD-L1/4-1BBL signaling and highlighted dual PD-L1/4-1BB targeting as a promising treatment. #medsky
#OpenAccess in #STTT: doi.org/10.1038/s413...
#Haematology #Oncology #Scotland #NHSScotland #multiplemyeloma #GSK #Blenrep #belantamabmafodotin #Blenrepcombination #lenalidomide #ScottishMedicinesConsortium #SMC #bortezomibanddexamethasone #BVd #SMCrecommendation #phase3data #DREAMM7study #progressionfreesurvival
zurl.co/ydmDa
The #FDA recently approved tafasitamab in combination with #rituximab and #lenalidomide to treat #FollicularLymphoma in adults, based on findings showing a 22.4-month median PFS with the therapy compared with 13.9 months in the control arm: ow.ly/uH9o50Wtk1R
#HemeSky #HemeOnc
Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma - Rahul Banerjee
@rahulbanerjeemd.bsky.social
oncodaily.com/drugs/financ...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MM #MultipleMyeloma #Myeloma #Lenalidomide
ACN comes to Bluesky with our May issue, out now! Click the link below to check out articles on the current state of cooperative #clinical trials, #factorVIII prophylaxis for #hemophilia, discontinuation of #lenalidomide maintenance in #MultipleMyeloma #MMsm, and more: tinyurl.com/cevpnjk8
#HemeSky
CEPHEUS by Saad Z. Usmani, et al is out
@rahulbanerjeemd.bsky.social
@szusmani.bsky.social
oncodaily.com/science/ceph...
#Bortezomib #Cancer #CD38VR #CEPHEUS #Daratumumab #Dexamethasone #FightAgainstCancer #IMROZ #Oncology #Lenalidomide #MultipleMyeloma #OncoDaily
